Table 3.
Frequency of COVID 19 related clinical trials in different states of India
| S. no. | State | Number of trials (N = 203) |
|---|---|---|
| 1 | Maharashtra | 53 (26.11) |
| 2 | Delhi | 51 (25.12) |
| 3 | Uttar Pradesh | 30 (14.78) |
| 4 | Tamil Nadu | 27 (13.30) |
| 5 | Karnataka | 24 (11.82) |
| 6 | Gujarat | 22 (10.84) |
| 7 | Andhra Pradesh | 17 (8.37) |
| 8 | Rajasthan | 16 (7.88) |
| 9 | Madhya Pradesh | 16 (7.88) |
| 10 | Chhattisgarh | 10 (4.93) |
| 11 | Telangana | 7 (3.45) |
| 12 | Chandigarh | 7 (3.45) |
| 13 | West Bengal | 5 (2.46) |
| 14 | Uttarakhand | 4 (1.97) |
| 15 | Haryana | 3 (1.48) |
| 16 | Puducherry | 2 (0.99) |
| 17 | Bihar | 2 (0.99) |
| 18 | Odisha | 2 (0.99) |
| 19 | Jammu & Kashmir | 1 (0.49) |
| 20 | Nagaland | 1 (0.49) |
| 21 | Meghalaya | 1 (0.49) |
| 22 | Goa | 1 (0.49) |